ClinVar Miner

Submissions for variant NM_000271.5(NPC1):c.2974G>T (p.Gly992Trp)

dbSNP: rs80358254
Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 11
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
Counsyl RCV000020230 SCV000220581 pathogenic Niemann-Pick disease, type C1 2014-08-07 criteria provided, single submitter literature only
Eurofins Ntd Llc (ga) RCV000723413 SCV000700313 uncertain significance not provided 2016-10-25 criteria provided, single submitter clinical testing
Invitae RCV000020230 SCV000941919 pathogenic Niemann-Pick disease, type C1 2024-01-27 criteria provided, single submitter clinical testing This sequence change replaces glycine, which is neutral and non-polar, with tryptophan, which is neutral and slightly polar, at codon 992 of the NPC1 protein (p.Gly992Trp). This variant is present in population databases (rs80358254, gnomAD 0.003%). This missense change has been observed in individuals with Niemann-Pick disease type C (PMID: 9634529, 11545687, 16778374, 20718790, 26666848, 28222799). It has also been observed to segregate with disease in related individuals. ClinVar contains an entry for this variant (Variation ID: 2960). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is expected to disrupt NPC1 protein function with a positive predictive value of 95%. This variant disrupts the p.Gly992 amino acid residue in NPC1. Other variant(s) that disrupt this residue have been determined to be pathogenic (PMID: 11333381, 16126423, 26984608). This suggests that this residue is clinically significant, and that variants that disrupt this residue are likely to be disease-causing. For these reasons, this variant has been classified as Pathogenic.
Baylor Genetics RCV000020230 SCV001163436 pathogenic Niemann-Pick disease, type C1 criteria provided, single submitter clinical testing
GeneDx RCV000723413 SCV001781732 pathogenic not provided 2022-10-10 criteria provided, single submitter clinical testing In silico analysis supports that this missense variant has a deleterious effect on protein structure/function; Not observed at significant frequency in large population cohorts (gnomAD); This variant is associated with the following publications: (PMID: 12955717, 11479732, 16778374, 12401890, 10521290, 11545687, 20718790, 9634529, 16126423, 24001525, 26666848, 29961769, 9245994, 31497485, 32222928, 20301473, 32138288, 34535129)
Revvity Omics, Revvity RCV000020230 SCV003815154 likely pathogenic Niemann-Pick disease, type C1 2022-03-15 criteria provided, single submitter clinical testing
OMIM RCV000003094 SCV000023252 pathogenic Niemann-Pick disease, type D 1998-07-01 no assertion criteria provided literature only
GeneReviews RCV000020230 SCV000040574 not provided Niemann-Pick disease, type C1 no assertion provided literature only
SingHealth Duke-NUS Institute of Precision Medicine RCV000020230 SCV000853138 likely pathogenic Niemann-Pick disease, type C1 2017-06-07 no assertion criteria provided curation
Natera, Inc. RCV000020230 SCV001453837 pathogenic Niemann-Pick disease, type C1 2020-09-16 no assertion criteria provided clinical testing
Hereditary Research Laboratory, Bethlehem University RCV000020230 SCV001653519 likely pathogenic Niemann-Pick disease, type C1 2021-06-02 no assertion criteria provided clinical testing

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.